| 000 | 01250 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250513220003.0 | ||
| 264 | 0 | _c20001208 | |
| 008 | 200012s 0 0 eng d | ||
| 022 | _a0031-6970 | ||
| 024 | 7 |
_a10.1007/s002280000148 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJohnson, M A | |
| 245 | 0 | 0 |
_aA study of the pharmacokinetic interaction between lamivudine and alpha interferon. _h[electronic resource] |
| 260 |
_bEuropean journal of clinical pharmacology _cJul 2000 |
||
| 300 |
_a289-92 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xadverse effects |
| 650 | 0 | 4 |
_aAntiviral Agents _xadverse effects |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 | _aHalf-Life |
| 650 | 0 | 4 |
_aHepatitis B _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon-alpha _xadverse effects |
| 650 | 0 | 4 |
_aLamivudine _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMetabolic Clearance Rate |
| 700 | 1 | _aJenkins, J M | |
| 700 | 1 | _aBye, C | |
| 773 | 0 |
_tEuropean journal of clinical pharmacology _gvol. 56 _gno. 4 _gp. 289-92 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s002280000148 _zAvailable from publisher's website |
| 999 |
_c10902902 _d10902902 |
||